Recent studies have demonstrated that KIF20A is overexpressed in many malignant tumors, including gastric cancer, glioma, bladder cancer, breast cancer, and prostate cancer (Li et al., 2019; Shen et al., 2019). Here, KIF20A is linked to urinary bladder carcinoma.